CLINICAL_TRIALS
trial_result
· 2020-04-15
Clinical Trial Update: Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure [Phase 3]
Summary
Phase 3 trial of avatrombopag for thrombocytopenia in adults undergoing procedures was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sobi, Inc. | Conditions: Thrombocytopenia | Phase 3 | Status: TERMINATED | Results posted: 2020-04-15